Nisshin Seifun Group saw the highest growth of 99% in patent filings in October and 166% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of Nisshin Seifun Group’s patent filings and grants. Buy the databook here.
Nisshin Seifun Group has been focused on protecting inventions in Japan(JP) with 11 publications in Q4 2023
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 19% filings and 55% grants. The World Intellectual Property Organization(WIPO), China(CN), Japan(JP), and United States(US) patent Office are among the top ten patent offices where Nisshin Seifun Group is filings its patents. Among the top granted patent authorities, Nisshin Seifun Group has 55% of its grants in Japan(JP), 27% in United States(US) and 9% in European Patent Office(EPO).
DSM-Firmenich could be the strongest competitor for Nisshin Seifun Group
Patents related to health & wellness and nanomedicine lead Nisshin Seifun Group's portfolio
Nisshin Seifun Group has the highest number of patents in health & wellness followed by, nanomedicine and nano tech. For health & wellness, nearly 25% of patents were filed and no patents were granted in Q4 2023.
Food related patents lead Nisshin Seifun Group portfolio followed by biocides, and pasta & noodles
Nisshin Seifun Group has highest number of patents in food followed by biocides, pasta & noodles, bakery and cereals, and petrochemicals. For food, nearly 17% of patents were filed and 10% of patents were granted in Q4 2023.
For comprehensive analysis of Nisshin Seifun Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.